198 related articles for article (PubMed ID: 37348915)
21. (68)Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma.
Lapa C; Lückerath K; Kleinlein I; Monoranu CM; Linsenmann T; Kessler AF; Rudelius M; Kropf S; Buck AK; Ernestus RI; Wester HJ; Löhr M; Herrmann K
Theranostics; 2016; 6(3):428-34. PubMed ID: 26909116
[TBL] [Abstract][Full Text] [Related]
22. [
Watts A; Singh B; Singh H; Bal A; Kaur H; Dhanota N; Arora SK; Mittal BR; Behera D
Eur J Nucl Med Mol Imaging; 2023 Mar; 50(4):1216-1227. PubMed ID: 36482077
[TBL] [Abstract][Full Text] [Related]
23.
Watts A; Singh B; Singh H; Kaur H; Bal A; Vohra M; Arora SK; Behera D
J Nucl Med Technol; 2022 Sep; 50(3):278-281. PubMed ID: 35610039
[No Abstract] [Full Text] [Related]
24. First-in-Human Experience of CXCR4-Directed Endoradiotherapy with 177Lu- and 90Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary Disease.
Herrmann K; Schottelius M; Lapa C; Osl T; Poschenrieder A; Hänscheid H; Lückerath K; Schreder M; Bluemel C; Knott M; Keller U; Schirbel A; Samnick S; Lassmann M; Kropf S; Buck AK; Einsele H; Wester HJ; Knop S
J Nucl Med; 2016 Feb; 57(2):248-51. PubMed ID: 26564323
[TBL] [Abstract][Full Text] [Related]
25. Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms Using
Buck AK; Haug A; Dreher N; Lambertini A; Higuchi T; Lapa C; Weich A; Pomper MG; Wester HJ; Zehndner A; Schirbel A; Samnick S; Hacker M; Pichler V; Hahner S; Fassnacht M; Einsele H; Serfling SE; Werner RA
J Nucl Med; 2022 Nov; 63(11):1687-1692. PubMed ID: 35241482
[TBL] [Abstract][Full Text] [Related]
26. First Experience with Chemokine Receptor CXCR4-Targeted PET Imaging of Patients with Solid Cancers.
Vag T; Gerngross C; Herhaus P; Eiber M; Philipp-Abbrederis K; Graner FP; Ettl J; Keller U; Wester HJ; Schwaiger M
J Nucl Med; 2016 May; 57(5):741-6. PubMed ID: 26769866
[TBL] [Abstract][Full Text] [Related]
27. CXCR4-targeted theranostics in oncology.
Buck AK; Serfling SE; Lindner T; Hänscheid H; Schirbel A; Hahner S; Fassnacht M; Einsele H; Werner RA
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4133-4144. PubMed ID: 35674738
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, Screening, and Evaluation of Theranostic Molecular CPCR4-Based Probe Targeting CXCR4.
Yang T; Shi D; Lin Q; Shen H; Tan H; Liu Y; Shi H; Cheng D
Mol Pharm; 2024 May; 21(5):2415-2424. PubMed ID: 38606663
[TBL] [Abstract][Full Text] [Related]
29.
Bouter C; Meller B; Sahlmann CO; Staab W; Wester HJ; Kropf S; Meller J
J Nucl Med; 2018 Feb; 59(2):320-326. PubMed ID: 28729430
[TBL] [Abstract][Full Text] [Related]
30. Chemokine receptor-4 targeted PET/CT with
Pan Q; Cao X; Luo Y; Li J; Feng J; Li F
Eur J Nucl Med Mol Imaging; 2020 Mar; 47(3):537-546. PubMed ID: 31776631
[TBL] [Abstract][Full Text] [Related]
31. 68 Ga-Pentixafor PET/CT for In Vivo Imaging of CXCR4 Receptors in Glioma Demonstrating a Potential for Response Assessment to Radiochemotherapy: Preliminary Results.
Waheed A; Singh B; Watts A; Kaur H; Singh H; Dhingra K; Ahuja C; Madan R; Singh A; Radotra BD
Clin Nucl Med; 2024 Apr; 49(4):e141-e148. PubMed ID: 38350065
[TBL] [Abstract][Full Text] [Related]
32. Reduced splenic uptake on
Kraus S; Klassen P; Kircher M; Dierks A; Habringer S; Gäble A; Kortüm KM; Weinhold N; Ademaj-Kospiri V; Werner RA; Schirbel A; Buck AK; Herhaus P; Wester HJ; Rosenwald A; Weber WA; Einsele H; Keller U; Rasche L; Lapa C
Theranostics; 2022; 12(13):5986-5994. PubMed ID: 35966583
[TBL] [Abstract][Full Text] [Related]
33. CXCR4 expression in glioblastoma tissue and the potential for PET imaging and treatment with [
Jacobs SM; Wesseling P; de Keizer B; Tolboom N; Ververs FFT; Krijger GC; Westerman BA; Snijders TJ; Robe PA; van der Kolk AG
Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):481-491. PubMed ID: 33550492
[TBL] [Abstract][Full Text] [Related]
34. Side Effects of CXC-Chemokine Receptor 4-Directed Endoradiotherapy with Pentixather Before Hematopoietic Stem Cell Transplantation.
Maurer S; Herhaus P; Lippenmeyer R; Hänscheid H; Kircher M; Schirbel A; Maurer HC; Buck AK; Wester HJ; Einsele H; Grigoleit GU; Keller U; Lapa C
J Nucl Med; 2019 Oct; 60(10):1399-1405. PubMed ID: 30850502
[TBL] [Abstract][Full Text] [Related]
35. CXCR4-Directed Imaging in Solid Tumors.
Werner RA; Kircher S; Higuchi T; Kircher M; Schirbel A; Wester HJ; Buck AK; Pomper MG; Rowe SP; Lapa C
Front Oncol; 2019; 9():770. PubMed ID: 31475113
[TBL] [Abstract][Full Text] [Related]
36. Chemokine Receptor CXCR4-Targeted PET/CT With 68Ga-Pentixafor Shows Superiority to 18F-FDG in a Patient With Waldenström Macroglobulinemia.
Luo Y; Pan Q; Feng J; Cao X; Li F
Clin Nucl Med; 2018 Jul; 43(7):548-550. PubMed ID: 29742593
[TBL] [Abstract][Full Text] [Related]
37. Imaging of chemokine receptor CXCR4 expression in culprit and nonculprit coronary atherosclerotic plaque using motion-corrected [
Derlin T; Sedding DG; Dutzmann J; Haghikia A; König T; Napp LC; Schütze C; Owsianski-Hille N; Wester HJ; Kropf S; Thackeray JT; Bankstahl JP; Geworski L; Ross TL; Bauersachs J; Bengel FM
Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1934-1944. PubMed ID: 29967943
[TBL] [Abstract][Full Text] [Related]
38. CT, MRI, and FDG-PET/CT imaging findings of abdominopelvic desmoplastic small round cell tumors: correlation with histopathologic findings.
Zhang WD; Li CX; Liu QY; Hu YY; Cao Y; Huang JH
Eur J Radiol; 2011 Nov; 80(2):269-73. PubMed ID: 20650589
[TBL] [Abstract][Full Text] [Related]
39. Imaging of Chemokine Receptor CXCR4 in Mycosis Fungoides Using 68Ga-Pentixafor PET/CT.
Kuyumcu S; Yilmaz E; Büyükkaya F; Özkan ZG; Ünal SN
Clin Nucl Med; 2018 Aug; 43(8):606-608. PubMed ID: 29916918
[TBL] [Abstract][Full Text] [Related]
40. Advances in PET Imaging of the CXCR4 Receptor: [
Lindenberg L; Ahlman M; Lin F; Mena E; Choyke P
Semin Nucl Med; 2024 Jan; 54(1):163-170. PubMed ID: 37923671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]